Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
After finishing at $8.21 in the prior trading day, CorMedix Inc (NASDAQ: CRMD) closed at $8.10, down -1.34%. In other words, the price has decreased by -$1.34 from its previous closing price. On the day, 0.71 million shares were traded. CRMD stock price reached its highest trading level at $8.15 during the session, while it also had its lowest trading level at $7.92.
Ratios:
Our goal is to gain a better understanding of CRMD by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.60 and its Current Ratio is at 3.96. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.01.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Rodman & Renshaw on August 26, 2024, initiated with a Buy rating and assigned the stock a target price of $13.
On August 10, 2023, RBC Capital Mkts started tracking the stock assigning a Outperform rating and target price of $6.
On February 17, 2021, Needham started tracking the stock assigning a Buy rating and target price of $31.Needham initiated its Buy rating on February 17, 2021, with a $31 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Oct 31 ’24 when Mistry Erin bought 1,500 shares for $9.99 per share. The transaction valued at 14,985 led to the insider holds 52,011 shares of the business.
Hurlburt Elizabeth sold 140,027 shares of CRMD for $1,565,670 on Nov 14 ’24. The EVP now owns 45,397 shares after completing the transaction at $11.18 per share. On Nov 14 ’24, another insider, Hurlburt Elizabeth, who serves as the Officer of the company, bought 140,027 shares for $11.12 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CRMD now has a Market Capitalization of 491485344 and an Enterprise Value of 446012256. For the stock, the TTM Price-to-Sale (P/S) ratio is 38.72 while its Price-to-Book (P/B) ratio in mrq is 7.99. Its current Enterprise Value per Revenue stands at 36.373 whereas that against EBITDA is -8.786.
Stock Price History:
Over the past 52 weeks, CRMD has reached a high of $13.85, while it has fallen to a 52-week low of $2.89. The 50-Day Moving Average of the stock is -20.25%, while the 200-Day Moving Average is calculated to be 21.16%.
Shares Statistics:
The stock has traded on average 1.15M shares per day over the past 3-months and 881250 shares per day over the last 10 days, according to various share statistics. A total of 60.68M shares are outstanding, with a floating share count of 59.77M. Insiders hold about 1.49% of the company’s shares, while institutions hold 31.41% stake in the company. Shares short for CRMD as of 1734048000 were 6728207 with a Short Ratio of 5.84, compared to 1731628800 on 6840218. Therefore, it implies a Short% of Shares Outstanding of 6728207 and a Short% of Float of 11.1.
